NFKB1 and metabolic dysfunction-associated steatotic liver disease: In line with the inactivation of NFκB, the inflammatory cytokines were also decreased after Ganweikang tablet treatment, which suggested that the treatment of NAFLD by Ganweikang tablet is partially through inactivating NFκB.